Related Experiment Video
Updated: Oct 25, 2025
A Probing Device for Quantitatively Measuring the Mechanical Properties of Soft Tissues during Arthroscopy
Published on: May 1, 2020
Raman needle arthroscopy for in vivo molecular assessment of cartilage
Kimberly R Kroupa1, Man I Wu1, Juncheng Zhang2
1Department of Mechanical Engineering, Boston University, Boston, Massachusetts, USA.
Abstract:
The development of treatments for osteoarthritis (OA) is burdened by the lack of standardized biomarkers of cartilage health that can be applied in clinical trials. We present a novel arthroscopic Raman probe that can "optically biopsy" cartilage and quantify key extracellular matrix (ECM) biomarkers for determining cartilage composition, structure, and material properties in health and disease. Technological and analytical innovations to optimize Raman analysis include (1) multivariate decomposition of cartilage Raman spectra into ECM-constituent-specific biomarkers (glycosaminoglycan [GAG], collagen [COL], water [H2 O] scores), and (2) multiplexed polarized Raman spectroscopy to quantify superficial zone (SZ) COL anisotropy via a partial least squares-discriminant analysis-derived Raman collagen alignment factor (RCAF). Raman measurements were performed on a series of ex vivo cartilage models: (1) chemically GAG-depleted bovine cartilage explants (n = 40), (2) mechanically abraded bovine cartilage explants (n = 30), (3) aging human cartilage explants (n = 14), and (4) anatomical-site-varied ovine osteochondral explants (n = 6). Derived Raman GAG score biomarkers predicted 95%, 66%, and 96% of the variation in GAG content of GAG-depleted bovine explants, human explants, and ovine explants, respectively (p < 0.001). RCAF values were significantly different for explants with abrasion-induced SZ COL loss (p < 0.001). The multivariate linear regression of Raman-derived ECM biomarkers (GAG and H2 O scores) predicted 94% of the variation in elastic modulus of ovine explants (p < 0.001). Finally, we demonstrated the first in vivo Raman arthroscopy assessment of an ovine femoral condyle through intraarticular entry into the synovial capsule. This study advances Raman arthroscopy toward a transformative low-cost, minimally invasive diagnostic platform for objective monitoring of treatment outcomes from emerging OA therapies.
Insights
A novel arthroscopic Raman probe offers an "optical biopsy" for cartilage, quantifying key biomarkers like glycosaminoglycan (GAG) and collagen (COL) to assess osteoarthritis (OA) progression and treatment efficacy.
Area of Science:
- Biomedical Engineering
- Spectroscopy
- Orthopedics
Background:
- Osteoarthritis (OA) treatment development is hindered by the absence of standardized biomarkers for cartilage health in clinical trials.
- Current methods lack objective measures for cartilage composition, structure, and material properties, crucial for monitoring OA.
- Need for minimally invasive techniques to assess cartilage in vivo for effective OA therapy evaluation.
Purpose of the Study:
- To introduce and validate a novel arthroscopic Raman probe for non-invasive cartilage assessment.
- To quantify key extracellular matrix (ECM) biomarkers, including glycosaminoglycan (GAG) and collagen (COL), in cartilage.
- To evaluate the probe's capability in determining cartilage composition, structure, and material properties for OA research.
Main Methods:
- Development of an arthroscopic Raman probe for 'optical biopsy' of cartilage.
- Application of multivariate decomposition to analyze Raman spectra and derive GAG, COL, and water (H2O) scores.
- Utilized multiplexed polarized Raman spectroscopy and partial least squares-discriminant analysis to quantify superficial zone COL anisotropy (RCAF).
- Ex vivo experiments on chemically GAG-depleted, mechanically abraded bovine cartilage, aging human cartilage, and ovine osteochondral explants.
- First in vivo Raman arthroscopy assessment performed on an ovine femoral condyle.
Main Results:
- Raman-derived GAG scores accurately predicted GAG content variation (95-96%) in bovine and ovine explants (p < 0.001).
- Raman collagen alignment factor (RCAF) values significantly differentiated explants with superficial zone COL loss (p < 0.001).
- Multivariate regression of Raman biomarkers (GAG, H2O) predicted 94% of elastic modulus variation in ovine explants (p < 0.001).
- Successful in vivo demonstration of Raman arthroscopy in an ovine model.
Conclusions:
- The novel arthroscopic Raman probe effectively quantifies critical ECM biomarkers in cartilage.
- This technology enables objective assessment of cartilage composition, structure, and mechanical properties.
- Raman arthroscopy presents a transformative, minimally invasive platform for monitoring OA treatment outcomes in clinical trials.
